Press Enter to activate screen reader mode.
Homepage
Navigation
Search
Content
Footer
Contact
Sitemap
Molecular Pharmacology
Main Navigation
Menu
Homepage
NEWS
About us
People
Research
Publications
Links
Location
Teaching
Services
Student portal
Alumni association
Staffnet
Contact
lock
Login
Search
search
en
Departments
ETH Zurich
chevron_right
D-CHAB
chevron_right
IPW
chevron_right
Molecular Pharmacology
Language Selection
English
You are here
Homepage
chevron_right
About us
chevron_right
MolPharm News
MolPharm News
Research Briefing: The story behind our discovery of BBLN and its involvement in cardiac malfunction in Tetralogy of Fallot (TOF).
02.11.2023
by Joshua Abd Alla
The Quitterer Group has published their new research findings on BBLN, CAMK2D and Tetralogy of Fallot (TOF) in the journal Nature Cardiovascular Research.
26.10.2023
by Joshua Abd Alla
The Quitterer Group has identified the Membrane Palmitoylated Protein 1 (MPP1) as a protein, which promotes heart failure in transgenic MPP1-mice and in different murine models with major cardiovascular risk factors. MPP1 could contribute to aging-induced cardiac degeneration because it is also up-regulated in peripheral blood mononuclear cells of aged humans.
06.09.2023
by Joshua Abd Alla
Our review on the different functions of RKIP on tumor cells and the heart has been published.
14.02.2022
by Joshua Abd Alla
Insight into the first disease-causing GPCR aggregation: the AT1R-B2R protein complex causes preeclampsia.
01.10.2021
by Joshua Abd Alla
add
Load more
JavaScript has been disabled in your browser